Featured Stories
Kanye West-Led Festival's Future Clouded as Anheuser-Busch InBev Joins Sponsor Exodus
Kanye West's UK festival in jeopardy: AB InBev joins PepsiCo & Diageo in pulling sponsorship over controversy. Is the event doomed?
Five Risks Jamie Dimon Is Worried About in 2026
Jamie Dimon warns of 5 critical risks for 2026: geopolitical shifts, stubborn inflation, tech threats, debt crisis, & green transition challenges. Prepare now.
McDonald’s CEO Responds to the Viral Big Arch Backlash
McDonald's CEO addresses the "Big Arch Backlash" over rising prices. Learn how Chris Kempczinski plans to restore value and affordability for customers.
Neurocrine to Acquire Soleno, Bolstering Rare Disease Pipeline with Prader-Willi Syndrome Treatment
Neurocrine acquires Soleno for $2.9B, strengthening its rare disease portfolio with DCCR, a promising treatment for Prader-Willi Syndrome's hyperphagia.
U.S. Services Sector Faced Heightened Inflation in March
US services inflation hits 4-year peak as energy prices surge from Iran war. See how businesses, consumers & the Fed are impacted by rising costs.
Treasury Taps BNY, Robinhood to Help Run Trump Accounts for Children
BNY Mellon & Robinhood named custodians for the new 'Trump Accounts for Children' initiative. Learn how this federal program will build financial futures for youth.
Nasdaq Opens Higher on Cease-Fire Efforts
Iran signals created a mixed stock market: Nasdaq rose on de-escalation hopes, while Dow slipped, reflecting persistent geopolitical tensions. Understand the impact.
Neurocrine to Buy Soleno for $2.9 Billion
Neurocrine acquires Soleno for $2.9B, adding DCCR for Prader-Willi Syndrome. A bold move to reshape rare disease therapy & address unmet PWS needs.
Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal
Neurocrine Biosciences acquires Soleno for $2.9B, boosting its rare disease portfolio with DCCR for Prader-Willi Syndrome. Addressing PWS hyperphagia.
NHTSA Closes Investigation into Tesla’s Summon Feature, Citing Low Crash Data
Federal regulators conclude Tesla Smart Summon investigation, citing minimal crashes. Learn why NHTSA closed the probe & what's next for Tesla's autonomy.
Opinion & Analysis
Stock Futures Rise on Cease-Fire Efforts
Stock futures surged today as U.S.-Iran peace talks intensify for a permanent end to war, signaling market optimism for lower oil and inflation relief.
Do Companies That Stack the Vote Do Worse?
Do corporate "vote stacking" tactics, like dual-class stock, hinder performance? Analyze how entrenched management impacts shareholder value, accountability, and strategy.
Jamie Dimon Warns of Higher Inflation, Interest Rates From Iran War
JPMorgan CEO Jamie Dimon warns a prolonged Iran conflict risks global stagflation, higher inflation, and interest rates. Learn its far-reaching economic impact.
JPMorgan Chase CEO Jamie Dimon Warns of Iran War's Inflationary Threat and Market Downturn
Jamie Dimon issues stark warning: Iran conflict risks surging inflation, aggressive rate hikes, and global market depression, potentially leading to stagflation.
Brands Adopt ‘No AI’ Disclaimers to Stand Out Amid the Slop
Tired of AI "slop"? Discover how brands use "No AI" disclaimers to signal authentic, human-created content, fostering trust & differentiation in a saturated market.
OpenAI Charts a Course for Superintelligence: What Their Policy Proposals Mean for Consumers
OpenAI unveils proactive policies for superintelligence. See how they plan to navigate advanced AI risks, ensure global governance, and equitable benefits for humanity.